The challenge of choosing in cardiovascular risk management

R.M. Hoogeveen, N.M.J. Hanssen, J.R. Brouwer, A. Mosterd, C.J. Tack, A.A. Kroon, G.J. De Borst, J. Ten Berg, T. Van Trier, J.R. Van Lennep, A. Liem, E. Serne, F.L.J. Visseren, J.H. Cornel, R.J.G. Peters, J.W. Jukema, E.S.G. Stroes*, PANORAMA working group

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Number of pages9
JournalNetherlands Heart Journal
DOIs
Publication statusE-pub ahead of print - 14 Jul 2021

Keywords

  • Cardiovascular disease
  • Cardiovascular risk management
  • Prevention
  • Atherosclerosis
  • Novel interventions
  • Drugs
  • DUAL ANTIPLATELET THERAPY
  • PREDICTION RULE
  • OUTCOMES
  • VALIDATION
  • PREVENTION
  • EVENTS
  • COMPLICATIONS
  • ASSOCIATION
  • RIVAROXABAN
  • SEMAGLUTIDE

Cite this